Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome
Abstract Background Dystonia is a key symptom in corticobasal syndrome (CBS), and upper limb dystonia is the most common phenotype. Dystonia‐associated pain is frequently reported and can be disabling, with poor benefit from oral treatments. Aims of the Study To investigate the role of botulinum tox...
Main Authors: | Elisa Unti, Sonia Mazzucchi, Rosanna Calabrese, Giovanni Palermo, Eleonora Del Prete, Ubaldo Bonuccelli, Roberto Ceravolo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-06-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.1182 |
Similar Items
-
Botulinum Toxin in the Treatment of Lingual Dystonia Induced by Speaking
by: F. Budak, et al.
Published: (2013-01-01) -
FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia
by: Lauren L. Spiegel, et al.
Published: (2020-05-01) -
Use of botulinum toxin in the management of dystonia in Parkinson’s disease
by: Charenya Anandan, et al.
Published: (2024-04-01) -
The Role of Ultrasound for the Personalized Botulinum Toxin Treatment of Cervical Dystonia
by: Urban M. Fietzek, et al.
Published: (2021-05-01) -
Treatment of cervical dystonia with botulinum toxin in a patient with myasthenia gravis
by: MARCIA RUBIA R. GONÇALVES, et al.
Published: (1999-09-01)